Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol
- 24 May 2019
- journal article
- case report
- Published by Elsevier in Parasitology International
- Vol. 72, 101934
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Drug resistance and treatment failure in leishmaniasis: A 21st century challengePLOS Neglected Tropical Diseases, 2017
- Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infectionParasitology International, 2016
- Human parasitic protozoan infection to infertility: a systematic reviewParasitology Research, 2015
- Immunomodulatory effects of chitin microparticles on Leishmania major-infected BALB/c miceParasitology International, 2015
- Leishmaniasis chemotherapy—challenges and opportunitiesClinical Microbiology and Infection, 2011
- Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not EndemicJournal of Clinical Microbiology, 2011
- A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapyInternational Journal of Clinical Pharmacy, 2011
- Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugsParasitology Research, 2007
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLOS Medicine, 2006
- Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993